Charging on the basis of the three FEESST CPT codes (31575, 92520-59, and 92525) plus the initial consult code resulted in a mean reimbursement of $230.
The average total reimbursement for FEESST was significantly lower than that for MBS (p[less than]0.
In summary, Medicare reimbursement for the initial inpatient FEESST was 28% less than that for MBS ($322.
The cost-effectiveness of FEESST compared with MBS in the diagnosis and management of dysphagia in patients with head and neck cancer can be more fully appreciated if one extrapolates the expected savings we found to the nation as a whole.
The advantages of FEESST over MBS extend to areas beyond direct reimbursement.
In contradistinction, FEESST is performed at the bedside by an otolaryngologist and an SLP, and transportation of the patient off the floor is not required.